Humanized anti-ghrelin antibodies
    38.
    发明授权
    Humanized anti-ghrelin antibodies 失效
    人源化抗Ghrelin抗体

    公开(公告)号:US07479271B2

    公开(公告)日:2009-01-20

    申请号:US11815379

    申请日:2006-02-09

    Abstract: Humanized antibodies, or antigen-binding portions thereof, that preferentially bind acylated ghrelin with respect to unacylated ghrelin, are disclosed. These molecules have high affinity and a slow off rate for acylated ghrelin, and neutralize acylated ghrelin activity. These antibodies, or antigen-binding portions thereof, are useful for neutralizing acylated ghrelin activity, e.g., in a subject suffering from a disorder in which ghrelin activity is detrimental, such as obesity.

    Abstract translation: 公开了相对于未酸化的生长素释放肽优先结合酰化的生长素释放肽的人源化抗体或其抗原结合部分。 这些分子对酰化的生长素释放肽具有高亲和力和缓慢的速率,并中和酰化的生长素释放肽活性。 这些抗体或其抗原结合部分可用于中和酰化的生长素释放肽活性,例如在患有生长素释放肽活性是有害的疾病如肥胖症的受试者中。

Patent Agency Ranking